These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26470602)

  • 1. Recent advances in the pathological understanding of eosinophilic esophagitis.
    Cianferoni A; Spergel JM; Muir A
    Expert Rev Gastroenterol Hepatol; 2015; 9(12):1501-10. PubMed ID: 26470602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From genetics to treatment of eosinophilic esophagitis.
    Cianferoni A; Spergel JM
    Curr Opin Allergy Clin Immunol; 2015 Oct; 15(5):417-25. PubMed ID: 26258919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-related apoptosis-inducing ligand (TRAIL) regulates midline-1, thymic stromal lymphopoietin, inflammation, and remodeling in experimental eosinophilic esophagitis.
    Collison AM; Sokulsky LA; Sherrill JD; Nightingale S; Hatchwell L; Talley NJ; Walker MM; Rothenberg ME; Mattes J
    J Allergy Clin Immunol; 2015 Oct; 136(4):971-82. PubMed ID: 25981737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of Eosinophilic Esophagitis: A Comprehensive Review of the Genetic and Molecular Aspects.
    Ryu S; Lee KH; Tizaoui K; Terrazzino S; Cargnin S; Effenberger M; Shin JI; Kronbichler A
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33008138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic esophagitis.
    Merves J; Muir A; Modayur Chandramouleeswaran P; Cianferoni A; Wang ML; Spergel JM
    Ann Allergy Asthma Immunol; 2014 May; 112(5):397-403. PubMed ID: 24566295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilic Esophagitis: Pathophysiology and Definition.
    Clayton F; Peterson K
    Gastrointest Endosc Clin N Am; 2018 Jan; 28(1):1-14. PubMed ID: 29129294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis.
    Noti M; Wojno ED; Kim BS; Siracusa MC; Giacomin PR; Nair MG; Benitez AJ; Ruymann KR; Muir AB; Hill DA; Chikwava KR; Moghaddam AE; Sattentau QJ; Alex A; Zhou C; Yearley JH; Menard-Katcher P; Kubo M; Obata-Ninomiya K; Karasuyama H; Comeau MR; Brown-Whitehorn T; de Waal Malefyt R; Sleiman PM; Hakonarson H; Cianferoni A; Falk GW; Wang ML; Spergel JM; Artis D
    Nat Med; 2013 Aug; 19(8):1005-13. PubMed ID: 23872715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of eosinophilic esophagitis.
    Kottyan LC; Rothenberg ME
    Mucosal Immunol; 2017 May; 10(3):580-588. PubMed ID: 28224995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-stromal crosstalk and fibrosis in eosinophilic esophagitis.
    Muir AB; Wang JX; Nakagawa H
    J Gastroenterol; 2019 Jan; 54(1):10-18. PubMed ID: 30101408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis of eosinophilic esophagitis.
    Blanchard C
    Curr Opin Gastroenterol; 2015 Jul; 31(4):321-7. PubMed ID: 26039724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE).
    Chandramouleeswaran PM; Shen D; Lee AJ; Benitez A; Dods K; Gambanga F; Wilkins BJ; Merves J; Noah Y; Toltzis S; Yearley JH; Spergel JM; Nakagawa H; Malefyt Rd; Muir AB; Wang ML
    PLoS One; 2016; 11(3):e0150968. PubMed ID: 26992000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic esophagitis: an immune-mediated esophageal disease.
    Weinbrand-Goichberg J; Segal I; Ovadia A; Levine A; Dalal I
    Immunol Res; 2013 Jul; 56(2-3):249-60. PubMed ID: 23579771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular, genetic, and cellular bases for treating eosinophilic esophagitis.
    Rothenberg ME
    Gastroenterology; 2015 May; 148(6):1143-57. PubMed ID: 25666870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMSY is increased and activates TSLP & CCL5 expression in eosinophilic esophagitis.
    Fahey LM; Guzek R; Ruffner MA; Sullivan KE; Spergel J; Cianferoni A
    Pediatr Allergy Immunol; 2018 Aug; 29(5):565-568. PubMed ID: 29663593
    [No Abstract]   [Full Text] [Related]  

  • 15. TRAIL deficiency and PP2A activation with salmeterol ameliorates egg allergen-driven eosinophilic esophagitis.
    Sokulsky LA; Collison AM; Nightingale S; Fevre AL; Percival E; Starkey MR; Hansbro PM; Foster PS; Mattes J
    Am J Physiol Gastrointest Liver Physiol; 2016 Dec; 311(6):G998-G1008. PubMed ID: 27742702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amniotic fluid modifies esophageal epithelium differentiation and inflammatory responses.
    Rochman M; Klinger AM; Caldwell JM; Sadovsky Y; Rothenberg ME
    Am J Physiol Gastrointest Liver Physiol; 2024 Nov; 327(5):G629-G639. PubMed ID: 39189791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.
    Judd LM; Heine RG; Menheniott TR; Buzzelli J; O'Brien-Simpson N; Pavlic D; O'Connor L; Al Gazali K; Hamilton O; Scurr M; Collison AM; Mattes J; Allen KJ; Giraud AS
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G13-25. PubMed ID: 26514775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13.
    Masuda MY; Pyon GC; Luo H; LeSuer WE; Putikova A; Dao A; Ortiz DR; Schulze AR; Fritz N; Kobayashi T; Iijima K; Klein-Szanto AJ; Shimonosono M; Flashner S; Morimoto M; Pai RK; Rank MA; Nakagawa H; Kita H; Wright BL; Doyle AD
    J Allergy Clin Immunol; 2024 May; 153(5):1355-1368. PubMed ID: 38310974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncanonical NF-κB signaling and the essential kinase NIK modulate crucial features associated with eosinophilic esophagitis pathogenesis.
    Eden K; Rothschild DE; McDaniel DK; Heid B; Allen IC
    Dis Model Mech; 2017 Dec; 10(12):1517-1527. PubMed ID: 29259025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disodium cromoglycate treatment reduces T
    Silva FMCE; de Oliveira EE; Ambrósio MGE; Ayupe MC; de Souza VP; Menegati LM; Reis DRL; Machado MA; Macedo GC; Ferreira AP
    Int Immunopharmacol; 2020 Jun; 83():106422. PubMed ID: 32251959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.